卢宠茂称「1+」审批机制扩展至所有新药仅改变模式 不代表降低水平
即時港聞2024-10-25
「1+」审批机制下月起扩展至所有新药 有药剂师料可增加竞争令药价下降
即時港聞2024-10-25
政府指治疗阵发性夜间血红素尿症新药 获准在港注册
即時港聞2024-07-05
医管局鼓励提供新药予特定患者药厂通过「1+」机制在港注册 扩大药物供应
即時港聞2024-05-12
新药审批机制下两款癌症新药获批
即時港聞2023-12-08
【施政报告】成立「大湾区国际临床试验所」 促进医管局临床研究及试验
即時港聞2023-10-24
逾八千志愿者为中大医学院测试新药安全性 惟寻找健康志愿者有难度
即時港聞2023-09-19
有公司指本港展開人體測試新藥困難重重 當局稱已推多項措施縮短審批時間
即時港聞2022-07-13
醫療：丙肝新藥具成效 學者倡為病人免費治療
即時港聞2017-03-06
醫療：本港近年引入丙肝新療法 可有效根治
即時港聞2016-08-08
學者指丙肝可致肝癌 新藥治癒率升至九成
即時港聞2014-07-16
中大成立一期臨床研究中心開發新藥
即時港聞2013-12-18
第 2 / 2 页
条款及细则
条款及细则
随时随地观看新闻，立即下载
'%3e%3cpath%20id='路径_2'%20data-name='路径%202'%20d='M579.91,145.916a42.433,42.433,0,1,0,42.528,42.433,41.772,41.772,0,0,0-42.528-42.433m0,68.138a25.8,25.8,0,1,1,23.91-25.705,24.572,24.572,0,0,1-23.91,25.705m-92.9-68.138a42.433,42.433,0,1,0,42.528,42.433,41.772,41.772,0,0,0-42.528-42.433m0,68.138a25.8,25.8,0,1,1,23.911-25.705,24.572,24.572,0,0,1-23.911,25.705m-110.38-55.1v17.956h42.621A37.793,37.793,0,0,1,409.8,199.6a44.037,44.037,0,0,1-33.266,13.135,47.914,47.914,0,0,1,0-95.734,45.836,45.836,0,0,1,32.415,12.854l12.664-12.664a62.75,62.75,0,0,0-45.174-18.144,66.153,66.153,0,1,0,0,131.739,60.2,60.2,0,0,0,45.93-18.9A59.452,59.452,0,0,0,438.154,170.2a58.644,58.644,0,0,0-.946-11.246Zm451.638,14.364a39.409,39.409,0,0,0-36.291-26.933A40.259,40.259,0,0,0,752,188.822a41.49,41.49,0,0,0,42.055,42.432,42.148,42.148,0,0,0,35.344-18.9l-14.459-9.45a24.193,24.193,0,0,1-20.885,11.718,21.546,21.546,0,0,1-20.6-12.852l56.7-23.436ZM770.431,187.5a23.249,23.249,0,0,1,22.21-24.76,16.441,16.441,0,0,1,15.781,9.45Zm-46.023,40.637h18.9V103.577h-18.9Zm-30.525-72.77h-.568a29.385,29.385,0,0,0-22.3-9.449,42.526,42.526,0,0,0,0,85.053,28.908,28.908,0,0,0,22.3-9.449h.663v6.142c0,16.256-8.7,24.854-22.681,24.854a23.431,23.431,0,0,1-21.358-15.12l-16.255,6.71a40.446,40.446,0,0,0,37.8,25.044c21.829,0,40.354-12.853,40.354-44.134V148.468H693.883Zm-21.359,58.594A24.381,24.381,0,0,1,648.9,188.443a24.57,24.57,0,0,1,23.625-25.894,23.909,23.909,0,0,1,22.682,25.894,23.722,23.722,0,0,1-22.682,25.611ZM915.592,103.484H870.985V228.135h18.9V180.883h25.988a38.747,38.747,0,1,0,0-77.4Zm.471,60.1H889.6V120.872h26.461a21.358,21.358,0,1,1,0,42.715m115.012-17.861a34.97,34.97,0,0,0-33.171,18.9l16.539,6.9a17.583,17.583,0,0,1,17.01-9.452,17.958,17.958,0,0,1,19.564,16.066v1.324a41.193,41.193,0,0,0-19.373-4.819c-17.767,0-35.913,9.449-35.913,28.35a28.352,28.352,0,0,0,30.9,27.407,26.277,26.277,0,0,0,23.722-12.191h.661v9.45h17.956v-47.44c-.095-22.115-16.539-34.5-37.9-34.5m-2.268,68.328c-6.047,0-14.552-3.024-14.552-10.585,0-9.45,10.583-13.325,19.751-13.325a33.169,33.169,0,0,1,17.011,4.159,22.588,22.588,0,0,1-22.21,19.751m105.468-65.586-21.357,54.057h-.663l-22.02-54.057H1070.2l33.172,75.6-18.9,42.054h19.374l51.128-117.563ZM966.718,228.135h18.9V103.577h-18.9Zm-840.431-101.5L4.377,4.631A20.131,20.131,0,0,0,.029,18.24V238.72a21.079,21.079,0,0,0,3.4,12.569Zm4.064-3.876,37.8-37.8L25.356,3.214A18.9,18.9,0,0,0,8.912.945Zm89.4-8.695L172.5,87.417l-38.652,39.221,41.3,41.3L219.28,142.8c14.46-7.844,14.46-20.791.472-28.73m-89.4,16.539L7.495,254.974a17.768,17.768,0,0,0,17.768-1.607l144.686-82.219h.566Z'%20fill='%23fff'/%3e%3c/g%3e%3c/svg%3e)
Copyright 2026 TVB Limited